Internal Medicine, Endocrinology, Diabetes, & Metabolism · Ashland, KY
NPI
1831196807
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2025 Carter Ave
Ashland, KY, 41101
Phone (606) 325-1894
Groups this clinician bills Medicare through
Medicare paid, 2024
$68K
1,297 services
Medicare patients, 2024
449
Average age 71
Drug cost, 2024
$3.8M
11,315 prescriptions
Company payments, 2025
$1,046
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hazel Yang was code 99214 (office e&m - established), 940 times for 436 patients. In total Hazel Yang billed 1,297 services in 6 codes, and Medicare paid $68K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-03-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 940 | 436 | $63.07 | $59K |
| 95251 Test - Miscellaneous | Office | 178 | 62 | $23.77 | $4,232 |
| 76536 Ultrasound - Nonspecific | Facility | 98 | 94 | $18.55 | $1,818 |
| 76536 Ultrasound - Nonspecific | Office | 32 | 31 | $14.89 | $476 |
| 99204 Office E&M - New | Office | 28 | 28 | $85.80 | $2,402 |
| 36415 Venipuncture Blood Collection | Office | 20 | 17 | $8.65 | $173 |
By year: 2022 $95K for 1,708 services; 2023 $80K for 1,489 services; 2024 $68K for 1,297 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 20 | 17 | $8.65 | $173 |
Medicare prescription drug claims, 2024
In 2024, the drug Hazel Yang prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,996 prescriptions and refills. In total Hazel Yang wrote 11,315 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,996 | 4,718 | 483 | $19K |
| Ozempic Semaglutide | 1,039 | 1,264 | 166 | $1.2M |
| Synthroid Levothyroxine Sodium | 517 | 1,148 | 115 | $30K |
| Pioglitazone Hcl Generic | 485 | 1,177 | 122 | $5,374 |
| Jardiance Empagliflozin | 481 | 881 | 106 | $514K |
| Metformin Hcl Generic | 467 | 1,106 | 124 | $2,937 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 467 | 938 | 128 | $115K |
| Glimepiride Generic | 344 | 769 | 89 | $2,472 |
| Lisinopril Generic | 302 | 743 | 82 | $1,607 |
| Simvastatin Generic | 273 | 759 | 82 | $2,008 |
| Atorvastatin Calcium Generic | 252 | 678 | 79 | $1,960 |
| Novolog Flexpen Insulin Aspart | 237 | 444 | 76 | $52K |
| Rosuvastatin Calcium Generic | 216 | 545 | 61 | $2,648 |
| Metformin Hcl Er Metformin Hcl | 212 | 500 | 55 | $1,548 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 204 | 397 | 81 | $20K |
Brand drugs: 5,319 claims; generic drugs: 5,163 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hazel Yang $1,046 ($1,046 in general payments such as food, travel and fees) from 13 companies. The largest payer was Novo Nordisk Inc with $278.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 16 | $278 |
| Insulet Corporation PODD | 13 | $163 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $154 |
| Lilly USA, LLC LLY | 6 | $110 |
| Beta Bionics, Inc. BBNX | 3 | $69.24 |
| Radius Health, Inc. | 1 | $50.56 |
| Medtronic, Inc. MDT | 2 | $47.23 |
| Abbott Laboratories ABT | 3 | $43.66 |
| Mannkind Corporation MNKD | 2 | $38.31 |
| Tandem Diabetes Care, Inc. TNDM | 2 | $38.09 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.